The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical Observation on Acute Cerebral Infarction Intervented by Thrombolytic Therapy
Author(s): 
Pages: 141-142
Year: Issue:  2
Journal: JOURNAL OF HENAN UNIVERSITY OF SCIENCE & TECHNOLOGY(MEDICAL SCIENCE)

Keyword:  脑梗塞选择性插管动脉溶栓;
Abstract: 目的评价选择性插管动脉溶栓治疗急性脑梗塞的临床应用价值.方法 38例患者于发病12 h内在DSA监视下,采用Seldinger技术,经股动脉置入6 F导管鞘后,按病人体重数的2/3的肝素毫克数进行首次抗凝,并每过1 h追加半量.先行全脑血管造影,将导管置于梗塞供血血管,给予尿激酶50万U加生理盐水50 ml,用微量泵以60 ml/h的速度推注,0.5 h后以相同条件和体位造影观察血管溶通情况,未通或部分再通者,追加尿激酶25万U,生理盐水25 ml.结果本组病人除5例为椎动脉系外,其余均为颈内动脉系闭塞, 溶栓后即刻完全再通10例,部分再通16例,未通12例,神经系统功能除2例意识障碍无明显改善,余均有较明显改善.其中并发脑出血2例,消化道出血1例.结论选择性动脉内溶栓安全可靠,是治疗急性脑梗塞的主要方法之一.
Related Articles
loading...